////// Science for a better life Global Breadcrumb Home Investors Investor News Stay Informed About Key Developments for Our Company The Latest Updates as They Happen As a valued partner in our shared success, you should be the first to know what’s happening across our company. The articles and announcements below offer a comprehensive glimpse into the recent developments that shape our business and growth strategies. News Pagination Current page 1 / Page 2 / Page 3 / Page 4 / Page 5 / Page 6 / Page 7 / Page 8 / Page 9 1 - 10 of about 651 News November 15, 2021 Not intended for U.S. and UK Media Bayer extends clinical development program for finerenone with Phase III study in children and adolescents with chronic kidney disease READ MORE November 11, 2021 Not intended for U.S. and UK Media New Phase III study to investigate expanded use of vericiguat in patients with chronic heart failure with reduced ejection fraction READ MORE November 10, 2021 Not intended for U.S. and UK Media Bayer Submits Aflibercept for regulatory approval in the EU and Japan for Retinopathy of Prematurity in premature babies READ MORE November 09, 2021 Third quarter of 2021: Bayer grows sales and earnings significantly READ MORE November 09, 2021 Effective January 1, 2022: Rodrigo Santos named member of the Board of Management, Bayer AG, and President of the Crop Science division READ MORE November 08, 2021 Not intended for U.S. and UK Media - The American Society of Nephrology (ASN)’s Kidney Week 2021: New data from finerenone clinical trial program reinforces renal and cardiovascular benefits in patients with CKD and T2D independent of baseline therapy READ MORE November 05, 2021 Not intended for U.S. and UK Media - The American Heart Association Scientific Sessions 2021: Bayer to present data from cardiovascular portfolio, including analyses from the comprehensive finerenone clinical trial program, VOYAGER PAD (Xarelto™) and the VICTORIA trial (Verquvo™) READ MORE October 29, 2021 Not intended for U.S. and UK Media European Patent Office maintained Bayer patent on the once-daily administration of rivaroxaban (Xarelto™) READ MORE October 27, 2021 Not intended for U.S. and UK Media – The American Society of Nephrology (ASN)’s Kidney Week 2021: Bayer to present new data from comprehensive finerenone clinical trial program READ MORE October 19, 2021 Bayer fuels leading market positions in Crop Science through delivery of unmatched innovation READ MORE Pagination Current page 1 / Page 2 / Page 3 / Page 4 / Page 5 / Page 6 / Page 7 / Page 8 / Page 9 1 - 10 of about 651 News Subscribe To Our Investor News Email Alerts Newsletter Subscription Ad-Hoc Releases Discover Bayer's Latest Ad-Hoc Releases READ MORE Last Updated: Monday, June 21, 2021 Our Business Pharmaceuticals Consumer Health Crop Science Our Products Bayer Worldwide Magazines & Reports News & Stories Annual Report Quarterly Report More Publications Stay Tuned Job Postings Latest News Newsletter Bayer Share Price Get in Touch Do you have any queries or comments? GLOBAL FORM REPORT A SIDE EFFECT Follow Us Copyright © Bayer AG Conditions of Use Privacy Statement Cookie Settings Imprint Sitemap